AAS (@atheroaussie) 's Twitter Profile
AAS

@atheroaussie

The Australian Atherosclerosis Society (AAS) promotes, at a national level, the advancement of science, research and teaching in the field of atherosclerosis

ID: 478220271

linkhttp://www.athero.org.au/ calendar_today30-01-2012 01:45:17

634 Tweet

474 Followers

230 Following

AAS (@atheroaussie) 's Twitter Profile Photo

After a brief break, we are back with Karen Birkenhead, who is sharing some of her work on multi-disciplinary care for FH in cardiology.

After a brief break, we are back with Karen Birkenhead, who is sharing some of her work on multi-disciplinary care for FH in cardiology.
AAS (@atheroaussie) 's Twitter Profile Photo

Closing out our morning session is Jennifer Della-Vedova, a leading patient advocate, updated audience on the newly formed FH Australia, a Voice for Inherited High Cholesterol.

Closing out our morning session is Jennifer Della-Vedova, a leading patient advocate, updated audience on the newly formed FH Australia, a Voice for Inherited High Cholesterol.
AAS (@atheroaussie) 's Twitter Profile Photo

We now move onto our Workshop session of the FH Summit. Natalie Taylor shares her thoughts on early implementation such as newborn screening can advance FH identification.

We now move onto our Workshop session of the FH Summit. Natalie Taylor shares her thoughts on early implementation such as newborn screening can advance FH identification.
AAS (@atheroaussie) 's Twitter Profile Photo

Closing out the FH Summit is the interactive workshop focusing on the development of risk-reduction pathway for children led by Mitchell Sarkies with insights from Shubha Srinivasan, Natalie Taylor & Andrew Martin.

Closing out the FH Summit is the interactive workshop focusing on the development of risk-reduction pathway for children led by <a href="/MitchellSarkies/">Mitchell Sarkies</a> with insights from Shubha Srinivasan, Natalie Taylor &amp; Andrew Martin.
AAS (@atheroaussie) 's Twitter Profile Photo

See link below to submit your abstract for #EASCongress2025. There are three travel bursaries available for AAS members to attend valued at €400 each!

AAS (@atheroaussie) 's Twitter Profile Photo

Our long standing AAS board member, Prof Gerald Watts, presented late-breaking data showing results of the PALISADE trial which identifies a new apoC3 inhibitor-based treatment to lower triglycerides and reduce pancreatitis in patients with FCS. Published in NEJM #ISA2024

Our long standing AAS board member, Prof Gerald Watts, presented late-breaking data showing results of the PALISADE trial which identifies a new apoC3 inhibitor-based treatment to lower triglycerides and reduce pancreatitis in patients with FCS. Published in NEJM #ISA2024
AAS (@atheroaussie) 's Twitter Profile Photo

Former AAS President and long time member, ChrisBursill delivered an excellent talk about the protective role of NRF2 activation in reducing plaque burden and instability #ISA2024

Former AAS President and long time member, <a href="/ChrisBursill/">ChrisBursill</a> delivered an excellent talk about the protective role of NRF2 activation in reducing plaque burden and instability #ISA2024